Market Synopsis
Multiphoton microscopy (MPM) is an efficient method for the imaging and analysis of tissues, since it provides high resolution, deep optical sectioning, a wide field of view, and reduced photo damage. Compared to other methods, MPM is ideal for functional imaging of biological tissues at a deeper level. The ability of MPM to distinguish between healthy and pathological tissues has been one of the most popular uses of the technology in medicine over the past several years. It is also effective in learning more about the causes and progression of different pathologies. Its applications are being expanded from basic research to the clinical setting. Such as the diagnosis of skin cancer, intestinal mucosal dysplasia, Alzheimer's disease, and metabolic abnormalities. This market holds a high growth potential due to the increase in the adoption of non-invasive imaging methods as well as the increase in research activities in developing countries.
Multiphoton Microscopy Market Segmentation
Segments
|
Details
|
By Type
|
Three Photon Microscopy; Two Photon Microscopy
|
By Application
|
Skin Imaging; Neuroscience; Oncology; Immunology; Dermatology
|
End-use
|
Hospitals; Clinics; Academic & Research Institutes
|
Region
|
North America; Europe; Asia Pacific; Latin America; MEA
|
Market Influencer
Multiphoton microscopy has gained importance as a non-invasive examination technology in recent years. With the introduction of new laser sources, fluorophores, and more specific probes, MPM and its applications are expected to expand into a variety of new fields in medicine. It is also used extensively in conjunction with other imaging techniques that offer complementary data, such as magnetic resonance imaging (MRI) or ultrasound. Furthermore, MPM relies on the simultaneous absorption of two or more photons by a fluorophore capacity to provide real-time imaging of a single cell and molecules in intact tissues and has come to take a major position in biomedical research.
MPM is widely used in a variety of applications including but not limited to neuroscience, oncology, dermatology, and immunology. Cancer prevalence is rising, leading to a growing demand for early diagnosis and treatment. According to the International Agency for Research on Cancer in 2020, globally 19,292,789 new cancer cases were diagnosed with 9,958,133 deaths in the same year.With advances in patient care, MPM is increasingly being used in cancer research facilities. As compared to confocal microscopy, MPM provides in-depth scanning of skin tissues using endogenous and exogenous fluorophores. This enhances its capabilities in dermatology research.
The key players operating in the multiphoton microscopy market include Nikon, Bruker, Toptica, Miltenyi Biotec, Semrock, and Thorlabs, Inc among others.